Robert Wood Johnson University Hospital Somerset to Host Free Cardiac Screenings for Young Athletes

Image

Somerville, NJ—Robert Wood Johnson University Hospital (RWJUH) Somerset, an RWJBarnabas Health hospital, will host its annual Cardiac Athletic Screening on Saturday, February 7, 2026, from 8 a.m. to 12 p.m., in the hospital’s Cardiac Diagnostic Testing Department, located on the second floor of the main hospital on Rehill Avenue. The free screening is available to young athletes ages 14 to 18 and is designed to help identify potential risk factors for sudden cardiac arrest. “We’ve conducted screenings for over 1,300 young athletes over the past 16 years we’ve offered the program,” says Steven Georgeson, MD, a cardiologist at RWJUH Somerset. 

“A cardiac screening may detect an underlying heart issue and prevent a tragic event in a young athlete.” Screenings will be conducted by RWJUH Somerset cardiologists, nurses, and technicians and include a cardiovascular history review, physical examination, blood pressure screening, body measurements, and an electrocardiogram (EKG). Echocardiograms will be performed when clinically indicated. 

The cardiac screening is free of charge, but advance registration is required. A parent or guardian must accompany each student. To register, please call 908-685-2414.
For more information, visit www.rwjbh.org/cardiacathleticscreening

RWJUH Somerset offers comprehensive cardiac care designed to support patients at every stage of heart health. 

By bringing advanced diagnostic testing, inpatient care, and specialized cardiac services together in one convenient location, the hospital provides seamless, coordinated care for patients and families. Cardiac diagnostic services include angiograms, computed tomography (CT) scans, single-photon emission computed tomography (SPECT), advanced Cardiac PET/CT imaging, echocardiograms, and ultrasounds. In addition to diagnostic and treatment services, RWJUH Somerset supports long-term recovery and wellness through a three-phase cardiac rehabilitation program located in Hillsborough. 

The hospital is recognized for its commitment to quality and patient outcomes, having earned The Joint Commission’s Gold Seal of Approval for its acute myocardial infarction program. RWJUH Somerset has been named among the Top 10% of hospitals nationwide for cardiology services by Healthgrades for four consecutive years and has received five-star ratings from Healthgrades for the treatment of heart attack and heart failure. In addition, U.S. News & World Report has recognized RWJUH Somerset as “high performing” in the treatment of heart failure patients, reflecting the hospital’s dedication to delivering high-quality cardiac care close to home. About Robert Wood Johnson University Hospital Somerset

Located in Somerville, Robert Wood Johnson University Hospital (RWJUH) Somerset, an RWJBarnabas Health facility, is a nationally accredited, 343-bed regional hospital providing comprehensive emergency, medical/surgical, behavioral health and rehabilitative services to central New Jersey residents. 

As a designated teaching hospital of Rutgers Robert Wood Johnson Medical School, the hospital maintains a family medicine residency program with 21 residents. RWJUH Somerset has earned significant national recognition for clinical quality and patient safety including the prestigious Magnet® Award for Nursing Excellence. As the first hospital in New Jersey to offer primary health care services for the LGBTQIA community, RWJUH Somerset has been honored as a Leader in LGBT Healthcare Equality by the Human Rights Campaign.

The Steeplechase Cancer Center at RWJUH Somerset has been designated as a Comprehensive Community Cancer Center by the American College of Surgeons’ Commission on Cancer. RWJBarnabas Health and RWJUH Somerset in partnership with Rutgers Cancer Institute of New Jersey - the state's only NCI-designated Comprehensive Cancer Center - bring a world class team of researchers and specialists to fight alongside you, providing close-to-home access to the latest treatment and clinical trials.

More News from Raritan
I'm interested
I disagree with this
This is unverified
Spam
Offensive